FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2024
Voltar para busca
Dado oficial do USPTO
ICAMUN BIOTHERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079352690Classe
5, 10, 35, 42, 44
Pedido
79352690
Registro
7318237
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
06/06/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 35, 42, 44
Data de depósito
02/06/2022
Data de registro
05/03/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/03/2024
Última transação
05/03/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Jiangsu Free Trade Zone, CN
Examinador
STANWOOD, STEPHEN D
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of, in a gradient from purple at the left to blue at the right, the stylized phrase "ICAMUNO BIOTHERAPEUTICS", with "ICAMUNO" above "BIOTHERAPEUTICS". The "O" in "ICAMUNO" is formed by a DNA double-helix design with one blue strand and one purple strand. All instances of the color white represent background or transparent areas only and are not a feature of the mark.
Titulares e representantes
Titulares
Suzhou Aikailiyuan Biotech Ltd.
Representantes
Michael T. Smith Birch Stewart Kolasch & Birch LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Biological preparations for medical purposes for the treatment of cardiovascular diseases and disordersophthalmic diseases and disordersrespiratory diseases and disordershyperlipidemiahypertensionpulmonary hypertensioncancerdiabetesinfectious diseaseshypercholesterolemiaallergiesinflammationpain; chemico-pharmaceutical preparations for the treatment of cardiovascular diseases and disordersophthalmic diseases and disordersrespiratory diseases and disordershyperlipidemiahypertensionpulmonary hypertensioncancerdiabetesinfectious diseaseshypercholesterolemiaallergiesinflammationpain; pharmaceutical preparations for the treatment of cardiovascular diseases and disordersophthalmic diseases and disordersrespiratory diseases and disordershyperlipidemiahypertensionpulmonary hypertensioncancerdiabetesinfectious diseaseshypercholesterolemiaallergiesinflammationpain; human vaccine preparations; antibiotics for human use; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; dietetic preparations adapted for medical purposes; depuratives for the body; Veterinary diagnostic reagents; veterinary vaccines; anti-infective products for veterinary use; veterinary preparationspain relief medication; Enzymes for veterinary purposes; biocides; babies' diaper-pants; cotton for medical purposes; medicinal preparations to facilitate teething; diapers for pets
Classe 10
Medical apparatus and instruments for monitoring vital signsblood properties and respiratory events; surgical apparatus and instruments for medical use; surgical apparatus and instruments for dental use; radiological apparatus for medical purposes; sanitary masks; protective masks for medical purposes; babies' bottles; Intra-uterine contraceptive devices; diaphragms for contraception; artificial heart valves; orthopedic apparatus for diagnostic and therapeutic use; suture materials
Classe 35
Advertising services; business consulting services; marketing services; personnel management consultancy; updating and maintenance of data in computer databases; accounting services; rental of vending machines; retail drug store services; wholesale drug store services; wholesale and retail store services featuring medical supplies
Classe 42
Scientific research and development; chemical research; development of pharmaceutical preparations and medicines; biomedical research services; medical research services; biotechnology research; pharmaceutical drug development services; pharmaceutical drug research services; drug testing servicesdrug screening for scientific research purposes; computer software design
Classe 44
Medical screening; provision of medical information; health counseling; health care; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; medical consultations; telemedicine services; mental health therapy services; physical therapy in the nature of movement therapy; veterinary specialty services providing advanced medicaldiagnostic or surgical services for animals
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
19/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/12/2023
PUBO
PUBLISHED FOR OPPOSITION
19/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/11/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/11/2023
RFNT
REFUSAL PROCESSED BY IB
31/05/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/05/2023
RFRR
REFUSAL PROCESSED BY MPU
10/05/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/03/2023
CPRA
PRIORITY ACTION WRITTEN
20/03/2023
DOCK
ASSIGNED TO EXAMINER
20/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/10/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/10/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ICAMUN BIOTHERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.